Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal versus intravenous ketamine for analgesia during cataract surgery
IRCT20200605047662N2Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Nasal Ketamin. Started Mar 2017; status: completed.
02
Drugs
ketamine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20200605047662N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200605047662N2.